Pro Doc Irbesartan/HCTZ Product Recall (2021-05-27)Health ProductsMay 27th, 2021 @ 12:00 AM
Basic Details
Issue: Product Safety
Category: Drugs
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Alert type: Drug Recall
Summary
Product
Pro Doc Irbesartan/HCTZ 150 mg/12.5 mg Tablet
Products
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|---|---|---|---|---|
| JR7823, JR7824, JU7506 | B. Pro Doc Irbesartan/HCTZ 300 mg/12.5 mg Tablet |
| DIN 02365170 | Tablet | Irbesartan 300 mg |
| JS0731 | C. Pro Doc Irbesartan/HCTZ 300 mg/25 mg Tablet |
| DIN 02365189 | Tablet | Irbesartan 300 mg |
| JN4976, JU3231, JY1913 | A. Pro Doc Irbesartan/HCTZ 150 mg/12.5 mg Tablet |
| DIN 02365162 | Tablet | Irbesartan 150 mg |
Introduction
-
Pro Doc Irbesartan/HCTZ 150 mg/12.5 mg Tablet
-
Pro Doc Irbesartan/HCTZ 300 mg/12.5 mg Tablet
-
Pro Doc Irbesartan/HCTZ 300 mg/25 mg Tablet
Reason
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.
Depth of distribution
Retailers
For more information
Recall Monitor
Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.
You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.
Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.
Recall Monitor is not endorsed by, or is an official product of the Government of Canada.
Made with in Vancouver, BC
© Mad Filaments Software Inc.